Zurcher Kantonalbank (Zurich Cantonalbank) Esperion Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$5.09 - $8.5 $60,927 - $101,745	11,970 New	11,970 $74,000
Q4 2021 Feb 01, 2022	SELL	$4.81 - $11.92 $14,146 - $35,056	-2,941 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$30.04 - $51.31 $23,491 - $40,124	782 Added 36.22%	2,941 $151,000
Q1 2020 May 06, 2020	BUY	$27.44 - $73.84 $22,171 - $59,662	808 Added 59.81%	2,159 $68,000
Q3 2018 Nov 09, 2018	BUY	$40.74 - $51.41 $7,455 - $9,408	183 Added 15.67%	1,351 $60,000
Q4 2017 Jan 31, 2018	BUY	$43.47 - $67.43 $16,257 - $25,218	374 Added 47.1%	1,168 $77,000
Q3 2017 Nov 08, 2017	BUY	$43.8 - $52.77 $34,777 - $41,899	794	794 $40,000

Others Institutions Holding ESPR

# of Institutions

207

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $171M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account